Background
==========

Cardiac involvement represents an important complication of b-thalassemia major, and results in increased mortality and morbidity rates. Disease mechanisms implicate iron infiltration of the heart structures due to frequent blood transfusions. Transfusion-dependent patients receive 20 times the normal intake of iron, which leads to iron accumulation and damage in the liver, heart, and endocrine organs \[[@B1]\]. Although iron chelating therapy has markedly improved outcomes, cardiac failure remains an important cause of death in thalassemic patients \[[@B2]\]. Therefore, early recognition of myocardial dysfunction is imperative, given the fact that majority of this patient group have preserved ejection fraction until late in disease process.

On the other hand, left atrial (LA) enlargement plays a pivotal role in the prognosis and management of various cardiovascular diseases, including coronary artery disease and heart failure \[[@B3],[@B4]\]. Recently real-time three-dimensional echocardiography (RT3DE) has been integrated into clinical practice, providing unique data on phasic changes of LA volume during the cardiac cycle \[[@B5]\]. Furthermore, it has been validated against cardiac magnetic resonance (CMR) and has been proven as a reliable and robust method for the evaluation of LA volume; being more accurate than conventional 2D echocardiography \[[@B6]\].

The aim of the current study is to investigate the performance of the left atrium in b-thalassemic patients with preserved left ventricular ejection fraction (EF) and no myocardial iron overload employing RT3DE.

Methods
=======

Study population
----------------

Twenty-eight consecutive asymptomatic patients (32.2 ± 4.3 yrs old, 17 men) with b-Thalassemia major were retrospectively studied, compared to twenty healthy age, sex- and BMI- matched controls. Thalassemic patients were on intense chelating therapy with deferipone (p.os) and desferioxamine (i.v/s.c). All patients were on sinus rhythm. Exclusion criteria included a medical history of smoking, arterial hypertension, diabetes mellitus, as well as the presence of heart failure and pulmonary hypertension symptoms (NYHA\> Stage I). Structural and valvular heart diseases were also within the exclusion criteria. Additionally, patients with CMR-detected myocardial iron overload during the previous six-month scan were excluded from the study. A critical iron loading was defined as a T2\* value less than the threshold of 20 ms (less than the lower limit value of the 95% confidence interval of the normal T2\* value as described by Anderson et al. \[[@B7]\]), and values equal to or greater than this limit were considered to be uncritical. On the other hand, the control group was consisted of individuals with unremarkable clinical history and normal findings on clinical examination; none of them was receiving medication affecting the cardiovascular system. The study was approved by our institution ethical committee.

Echocardiographic examination
-----------------------------

Transthoracic echocardiographic studies, including, 2-dimensional echocardiography, pulsed Doppler, colour Doppler, tissue Doppler imaging, and RT3D echocardiography, were performed in all patients, after placing them in the left decubitus position. The echo study was performed 2-3 days after blood transfusion. For this purpose the Philips iE33 ultrasound machine was used which was fully equipped with a 2D transducer and a matrix array transducer for 3D data acquisition.

The 2D data were acquired using the 2.5 MHz S5-1 transducer. The dynamic range of this system was 40 Db. Conventional measurements were obtained from parasternal long-axis view. Peak velocities during rapid filling, atrial contraction (A), were measured using pulsed Doppler echocardiography from the apical 4-chamber view by positioning the sample volume at the tips of the mitral valve, and the E/A ratio was subsequently calculated. The early diastolic mitral annular velocity (E\') was measured at the septal side of the mitral annulus using tissue Doppler imaging in the apical 4-chamber view. The ratio E/E\' was estimated as a non-invasive LV filling pressure index.

Real-Time Three Dimensional Echocardiography and Image analysis
---------------------------------------------------------------

Real-time 3-dimensional echocardiography imaging was performed from the apical window using a commercial scanner equipped with a fully sampled matrix array transducer (x3-1), in the harmonic mode. Two full-volume data sets were acquired from an apical window over seven cardiac cycles, with a breath hold. The 3-dimensional data sets were transferred to a Q-Lab system (Philips Medical Systems, Andover, Massachusetts) for off-line analysis. Analysis of 3-dimensional images was based on a 2-dimensional approach, which relied on obtaining images from an apical 4-chamber view (Additional File [1](#S1){ref-type="supplementary-material"}). Subsequently a semi-automated tracing of the LA endocardial surface was generated in order to calculate the LA volume. Tracing was performed by marking five atrial points: the anterior, inferior, lateral, septal mitral annuli, and the midpoint of the LA posterior wall in a 4-chamber view. Once this was completed, the endocardial border was automatically delineated, and the LA volume was obtained throughout the heart cycle, resulting in LA volume-time curves (Figures [1](#F1){ref-type="fig"},[2](#F2){ref-type="fig"},[3](#F3){ref-type="fig"}). Manual modifications were made to correct the automatic tracings in some patients.

![**Assessment of LA volumes using RT3DE**. Automatic border detection is obtained marking 5 reference points in the apical 2- and 4-chamber views (upper panel) and the LA 3-dimensional model is provided by the software (lower panel). The figure captures an end-systolic frame, from which left atrial maximum volume is derived.](1476-7120-9-38-1){#F1}

![**Estimation of minimum left atrial volume in the same patient using RT3DE (end-diastolic frame)**.](1476-7120-9-38-2){#F2}

![**Assessment of LA volume just before the atrial contraction (VpreA)**.](1476-7120-9-38-3){#F3}

LA volumes were measured at 3 time points of the cardiac cycle: (1) maximum volume (Vmax) at end-systole, just before mitral valve opening; (2) minimum volume (Vmin) at end-diastole, just before mitral valve closure; and (3) volume before atrial active contraction (VpreA) obtained from the last frame before mitral valve reopening or at time of the P wave on the surface electrocardiogram.

All 3D LA volumes were independently assessed by two echocardiographers (C.A and I.F).

LA volume definitions
---------------------

LA passive emptying volume (PAEV) was defined as the maximum LA volume minus the LA volume before atrial contraction (PAEV = Vmax-VpreA). LA active emptying volume (AAEV) was defined as the LA volume before atrial contraction minus the minimum LA volume (AAEV = VpreA-Vmin). For the assessment of the LA function the following indicators derived from volumes were used: left atrium active emptying fraction defined as (AAEF) = (VpreA-Vmin)/VpreAx100; and LA passive emptying fraction (PAEF) = (Vmax-VpreA)/Vmax100.

Statistical Analysis
--------------------

Continuous variables are presented as mean ± standard deviation of the mean or as percentage where appropriate. Data were tested for normality by Kolmogorov-Smirnov test. The means of normally distributed data were compared using independent Student\'s t-test. A value of p \< 0.05 was considered significant in all cases. All tests were two-tailed. Intra- and inter-observer agreement was assessed with the kappa statistic. Kappa statistic values are expressed as k ± std. error. Intervals of agreement are denoted as: kappa value greater than 0.800 denotes excellent agreement, 0.601-0.800 good agreement, 0.401-0.600 moderate agreement, 0.400 or less poor agreement. Data analysis was performed using the SPSS 17.0 statistical package for Windows (SPSS Inc, Chicago).

Results
=======

Twenty eight patients (32 yrs old, 17 men) as well as twenty healthy controls (31 ± 5.1 yrs old, 11 men) were enrolled in the study. All patients with beta- thalassemia were on chelating therapy and had no myocardial iron according to CMR. Patient demographics are illustrated in Table [1](#T1){ref-type="table"}.

###### 

Study population characteristics.

  *Variable*                             *Patients*     *Controls*     *P*
  -------------------------------------- -------------- -------------- ------
  **Age (years old)**                    32.2 ± 4.3     31 ± 5.1       0.4
  **Sex (male/female)**                  17/11          11/9           0.7
  **BMI (kgr/m^2^)**                     21.3 ± 3.8     22.1 ± 5.3     0.2
  **BSA (m^2^)**                         1.2 ± 0.3      1.3 ± 0.1      0.1
  **Systolic BP (mmHg)**                 112.3 ± 12.9   114.2 ± 12.8   0.6
  **Diastolic BP (mmHg)**                72.3 ± 7.9     75.8 ± 6.1     0.1
  **Heart Rate (bpm)**                   77.2 ± 10.3    72.1 ± 8.2     0.07
  **Medications**                                                      
  **Iron chelating therapy(n of pts)**   28             \-             
  **Biochemical Data**                                                 
  **Mean Serum feritin levels (μg/l)**   111 ± 84       \-             
  **Signa-MRI T2\*heart (ms)**           36.9 ± 5.6     \-             

Values are expressed as mean and standard deviation. In all case differences were not statistically significant (p = NS).

Measurements regarding conventional two-dimensional echo as well Doppler indices were similar between the 2 groups (tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). The average LA diameter obtained by 2D-echo was 36.2 vs. 35.5 mm for the patient and control groups respectively. It should be noted that the participants had normal ejection fraction. There was no statistical difference between the two groups with regards to 2D measurements and Doppler findings (conventional and TDI derived).

###### 

Echocardiographic data derived by conventional 2D measurements.

  *Parameters*                                *Patients*   *Controls*   *p*
  ------------------------------------------- ------------ ------------ -----
  **LA diameter (mm)**                        36.2 ± 4.1   35.5 ± 3.5   0.5
  **Ascending Aorta (mm)**                    27.9 ± 2.7   29.3 ± 3.4   0.1
  **End-diastolic diameter of the LV (mm)**   44.8 ± 3.4   46.1 ± 2.6   0.1
  **End-systolic diameter of the LV(mm)**     29.4 ± 1.5   28,9 ± 1,2   0.4
  **Ejection Fraction (%)**                   59 ± 2.5     60.0 ± 2.1   0.1
  **Intraventricular septum diameter (mm)**   8.2 ± 0.8    8.2 ± 0.9    0.9
  **LV posterior wall diameter (mm)**         8.2 ± 0.8    8.2 ± 0.8    0.8
  **RV diameter (mm)**                        27.9 ± 1.9   27.4 ± 1.7   0.3

Values are expressed as mean and standard deviation. LA = left atrial; LV = left ventricle; RV = right ventricle. In all cases differences were not statistically significant (p = NS).

###### 

Pulse Doppler and TDI parameters.

  *Variable*        *Patients*    *Controls*    *p*
  ----------------- ------------- ------------- -----
  **E (cm/s)**      67.7 ± 5.9    70.45 ± 8.0   0.1
  **A (cm/s)**      45.25 ± 5.9   45.6 ± 5.7    0.8
  **E/A**           1.5 ± 0.1     1.6 ± 0.1     0.3
  **E\' (cm/s)**    13.9 ± 1.9    14.3 ± 2.0    0.5
  **E/E\'**         4.9 ± 0.8     4.9 ± 0.7     0.9
  **IVRT (msec)**   59 ± 31       61 ± 28       0.6
  **DT (msec)**     141 ± 38      136 ± 44      0.8

Values are expressed as mean and standard deviation. IVRT = isovolumic relaxation time; DT = deceleration time. In all cases differences were not statistical significant (p = NS).

RT3DE reported no differences with regards to the phasic changes of atrial volumes (Table [4](#T4){ref-type="table"}). The mean left atrial maximum volume assessed by 3D-echo was 35.5 vs. 31.8 ml, while the mean left atrial minimum volume obtained by 3D-echo was 16.0 vs. 13.5 ml, for the patient and control groups respectively. Moreover, mean left atrial emptying volumes both passive (10.3 vs. 7.5 ml for patients and control respectively) and active (9.3 vs. 10.8 ml for patients and controls respectively), were not statistically different. On the contrary, the mean atrial active emptying fraction was significantly lower in the patient vs. the control group (34.2 vs. 48.3 ml respectively), while the mean passive emptive fraction was similar for both groups (patients 27.5 vs. controls 22.5 ml), as illustrated in Figure [4](#F4){ref-type="fig"}.

###### 

Left atrial volumes (ml) as calculated by RT3D

  *P*         *Patients*    *Controls*
  ----------- ------------- ------------
  **Vmax**    35.5 ± 13.4   31.8 ± 9.8
  0.2                       
  **Vmin**    16.0 ± 6.0    13.5 ± 4.2
  0.1                       
  **VpreA**   25.4 ± 9.8    24.3 ± 7.2
  0.7                       
  **AAEV**    9.3 ± 5.1     10.8 ± 4.7
  0.3                       
  **TAEV**    19.7 ± 9.7    18.2 ± 8.3
  0.5                       
  **PAEV**    10.3 ± 7.6    7.5 ± 3.7
  0.1                       

Values are expressed as mean and standard deviation. AAEV = active atrial emptying volume; TAEV = total atrial emptying volume; PAEV = passive atrial emptying volume; TAEV = total atrial emptying volume.

![**Graph illustrating atrial emptying fractions (% mean values)**.](1476-7120-9-38-4){#F4}

The agreement between the two readers was 0.918 ± 0.012 (0.894-0.942 95% C.I). Intra-observer agreement was 0.892 ± 0.017 (0.859-0.925, 95% C.I).

Discussion
==========

According to our knowledge, this is the first study that attempts to assess phasic changes of LA volumes in asymptomatic patients with b-thalassemia major by employing RT3D technology. As indicated by RT3D volumetric measurements, AAEF appears reduced in the patient population. This reflects abnormal systolic function of the LA, even in the absence of other affected echocardiographic parameters. This in turn could be explained by the fact that our patients were on intense chelating therapy, which maintained tissue iron levels within normal range (as illustrated by serum ferritin levels); therefore no iron accumulation was reported in the CMR evaluation. Indeed, studies have demonstrated that intense chelating therapy may prevent myocardial systolic function deterioration or even improve it \[[@B8]\]. Moreover, it should be noted that our patients did not have co-morbidities such as arterial hypertension or diabetes mellitus, which could potentially affect myocardial systolic and diastolic performance, and thus confound our results.

Iron toxicity is a major determinant of disease prognosis in b-thalassemic patients \[[@B9]\]. Although MRI is the gold standard in assessing early iron accumulation in the myocardium, echo is more widely available and cheaper. Monitoring ejection fraction can be useful, but its value is limited by the masking of ventricular dysfunction via the basal high cardiac output seen in chronic anaemia, and its late occurrence in the disease process \[[@B10]\]. Even modern contractile measures, such as tissue Doppler imaging, correlate poorly with cardiac iron. In a TDI study conducted by Silvilairat et *al*. \[[@B11]\], diastolic dysfunction was completely absent in patients who had ferritin levels below 2500 ng/ml. This observation was consistent with our results. Furthermore, data by Kremastinos \[[@B12]\] illustrated diastolic abnormalities only after the onset of cardiac failure. Margi et *al*. \[[@B13]\] have suggested strain indices as potential markers of early myocardial dysfunction in young asymptomatic patients, who nevertheless had myocardial iron as suggested by the reduced T2\* values on MRI. Again in that study all conventional echo measurements failed to illustrate any significance between the patient and the healthy control groups.

On the other hand, left atrial volumetric assessment employing RT3D seems to offer an alternative approach as it can provide useful clinical information in early disease states, regardless of the left ventricular ejection fraction \[[@B5]\]. In our study, the impaired AAEF reflects early dysfunction of the left atrium, which could be attributed to the fact that the LA is formed by thin walls that are earlier affected as compared to the left ventricular wall. The early impairment of left atrial function in thalassemia major has also been implicated by studies in asymptomatic thalassemic individuals employing biochemical parameters such as atrial natriuretic peptides \[[@B14],[@B15]\]. In addition to that, Trikas et *al*. have illustrated that LAEF was reduced in well-preserved thalassemic patients, a finding that was verified by our results. According to the same authors, this reduction was associated with reduced exercise capacity \[[@B16]\].

The echocardiographic evaluation of LA dimensions and performance is a matter of intense research. LA diameters as measured with 2D and M-Mode from the parasternal view tend to underestimate the true atrial dimensions, although they are useful and widely available \[[@B17]\]. Enlargement of the LA is often asymmetrical and may occur in the medial-lateral as well as the superior-inferior axes, due to limited anteroposterior axis enlargement by the thoracic cavity. These limitations led to the establishment of atrial volumes as more accurate indices for the evaluation of LA dimensions \[[@B18],[@B19]\]. Although LA volumes are influenced by body type, this was not the case in our study since both groups had similar BMI and BSA. As suggested by Cameli \[[@B20]\] and other investigators \[[@B21]\], a relatively novel technique for the assessment of atrial function would be the utilization of strain rate imaging. As stated by the authors, this could provide a useful insight into the pathophysiology of various cardiovascular diseases, since it is a feasible and reproducible technique. It should be noted though that this method has major limitations, such as the inability of capturing a region of interest resembling the atrial shape or the confounding effects on the echo signal by structures surrounding the left atrium \[[@B20]\].

More recently, LA volume has been measured using real-time 3D echocardiography that has shown good agreement with other imaging modalities including magnetic resonance imaging \[[@B22],[@B23]\]. Additionally, 3DE direct volumetric and 3D speckle-tracking methods give comparable and reproducible quantification of LV and LA volumes and function; this renders interchangeable application a viable option in daily clinical practice \[[@B24]\]. Left atrial volume assessment by 3D echocardiography has the most favourable test-retest variation with the least intra- and inter-observer variability compared with other echocardiographic techniques, with good correlations between biplane 2D and 3D measurements \[[@B25]\]. Moreover, RT3D can overcome limitations due to geometric assumptions, which is a main drawback of the two-dimensional approach \[[@B26]\]. For all these reasons, RT3D was chosen as the method of reference for the more accurate evaluation of LA volumes.

However, studies on 3D echo measurement of LA volume have been limited, and there is no consensus on the methods or comparisons with established normal values. In addition, the low frame-rates achieved by the X3-1 transducer constitute a major limitation. Furthermore, we did not employ strain and strain rate measurements, which could provide information on early atrial involvement in our study population \[[@B13],[@B27]\]. Biochemical parameters such as natriuretic peptides have not been assessed, which could lead to correlations of clinical significance.

Conclusions
===========

Real-time 3D seems to be a novel method for the accurate assessment of LA phasic changes in asymptomatic patients with b-thalassemia major. Additionally, AAEF may represent an early index of impaired left atrial performance in the specific population. In turn, left atrial dysfunction could be related to the increased incidence of arrhythmias and reduced functional capacity during exercise in thalassemic patients. Our results imply that left atrial function should be thoroughly investigated by clinicians.
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